| S-nitrosated α-1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis. | |
| | |
MedLine Citation:
|
PMID: 23047897 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Treating infections with exogenous NO, which shows broad-spectrum antimicrobial activity, appears to be effective. Similar to NO biosynthesis, biosynthesis of α-1-acid glycoprotein variant A (AGPa), with a reduced cysteine (Cys149), increases markedly during inflammation and infection. We hypothesized that AGPa is an S-nitrosation target in acute-phase proteins. This study aimed to determine whether S-nitrosated AGPa (SNO-AGPa) may be the first compound of this novel antibacterial class against multidrug-resistant bacteria. AGPa was incubated with RAW264.7 cells activated by lipopolysaccharide and interferon-γ. The antimicrobial effects of SNO-AGPa were determined by measuring the turbidity of the bacterial suspensions in vitro and survival in a murine sepsis model in vivo, respectively. Results indicated that endogenous NO generated by activated RAW264.7 cells caused S-nitrosation of AGPa at Cys149. SNO-AGPa strongly inhibited growth of gram-positive, gram-negative, and multidrug-resistant bacteria and was an extremely potent bacteriostatic compound (IC(50): 10(-9) to 10(-6) M). The antibacterial mechanism of SNO-AGPa involves S-transnitrosation from SNO-AGPa to bacterial cells. Treatment with SNO-AGPa, but not with AGPa, markedly reduced bacterial counts in blood and liver in a mouse sepsis model. The sialyl residues of AGPa seem to suppress the antibacterial activity, since SNO-asialo AGPa was more potent than SNO-AGPa.-Watanabe, K., Ishima, Y., Akaike, T., Sawa, T., Kuroda, T., Ogawa, W., Watanabe, H., Suenaga, A., Kai, T., Otagiri, M., Maruyama, T. S-nitrosated α-1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis. |
| | |
Authors:
|
Kaori Watanabe; Yu Ishima; Takaaki Akaike; Tomohiro Sawa; Teruo Kuroda; Wakano Ogawa; Hiroshi Watanabe; Ayaka Suenaga; Toshiya Kai; Masaki Otagiri; Toru Maruyama |
Related Documents
:
|
7906967 - Phylogenetic relationships among laboratory and wild-origin mus musculus strains on the... 2642547 - Dna synthesis, blood flow, and glucose utilization in experimental rat brain tumors. 4068657 - A mouse model for entamoeba histolytica infection. 21227987 - Genetic characterization indicates that a specific subpopulation of pseudomonas aerugin... 6349987 - Potential significance of colonization with beta-lactamase-producing haemophilus parain... 7906967 - Phylogenetic relationships among laboratory and wild-origin mus musculus strains on the... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-10-9 |
Journal Detail:
|
Title: FASEB journal : official publication of the Federation of American Societies for Experimental Biology Volume: - ISSN: 1530-6860 ISO Abbreviation: FASEB J. Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8804484 Medline TA: FASEB J Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
*Department of Biopharmaceutics and. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Programmable nanoparticle functionalization for in vivo targeting.
Next Document: p210bcr-abl induces amoeboid motility by recruiting ADF/destrin through RhoA/ROCK1.